Activation of neutrophil-like HL-60 cells by prostaglandin E2

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 54, Issue 3, 1996, Pages 199-205

  Wise, H ^a   Xie, Z H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 17 PHENYLPROSTACYLANDIN E2; BUTAPROST; CALCIUM; CICAPROST; GR 63799X; ILOPROST; MISOPROSTOL; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID RECEPTOR; SC 46275; SULPROSTONE; UNCLASSIFIED DRUG;

ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0029968128     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90017-4     Document Type: Article

References (33)

1. Gryglewski R. J., Salvemini D. Modulation of polymorphonuclear leukocyte function by prostaglandins and nitric oxide. In: Rubanyi G. M., Vane J, eds. Prostacyclin: New Perspectives for Basic Research and Novel Therapeutic Indications. Amsterdam: Elsevier Science Publishers, 1992: 59-92.
2. 2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun 1983; 113: 506-512.
3. 2+. Biochem J 1984; 224: 629-635.
4. 2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. Eicosanoids 1991; 4: 21-28.
5. Coleman R. A., Kennedy I., Humphrey P. P. A., Bunce K., Lumley P. Prostanoids and their receptors. In: Mansch C, Sammes P. G., Taylor J., eds. Comprehensive Medicinal Chemistry. Oxford: Pergamon Press, 1990: 642-714.
6. Wheeldon A., Vardey C. J. Characterization of the inhibitory prostanoid receptors on human neutrophils. Br J Pharmacol 1993; 108: 1051-1054.
7. Wise H., Jones R. L. Characterization of prostanoid receptors on rat neutrophils. Br J Pharmacol 1994; 113: 581-587.
8. Talpain E., Armstrong R. A., Vardey C., Coleman R. A. Characterisation of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br J Pharmacol 1994; 11: 25P.
9. Coffins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978; 75: 2458-2462.
10. Collins S. J., Ruscetti E W., Gallagher R. E., Gallo R. C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethyl sulfoxide. J Exp Med 1979; 149: 969-974.
11. Harris P., Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukot Biol 1985; 37: 407-422.
12. Li S. W., McKechnie K. C. W., Westwick J., Boughton-Smith N. K. Comparison of prostanoid EP agonist responses in human neutrophils and HL-60 cells. Adv Prostaglandin Thromboxane Leukot Res 1994; 22: In press.
13. Armstrong R. A., Talpain E. Comparison of the prostaglandin E (EP) receptor of human neutrophils and HL-60 cells differentiated with DMSO. Prostaglandins 1994; 4: 221-234.
14. Hoffstein S. T., Friedman R. S., Weissmann G. Degranulation, membrane addition, and shape change during chemotactic factor-induced aggregation of human neutrophils. J Cell Biol 1982; 95: 234-241.
15. Lai K. N., Lockwood C. M. The effect of anti-neutrophil cytoplasm autoantibodies on the signal transduction in human neutrophils. Clin Exp Immunol 1991; 85: 396-401.
16. Ford-Hutchinson A. W., Evans J. F. Neutrophil aggregation and chemokinesis assays. Methods Enzymol 1988; 162: 72-78.
17. 2+ efflux. Biochem J 1989; 264: 357-364.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.
19. De Lean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol 1978; 235: E97-E102.
20. 4 by human polymorphonuclear leukocytes. Br J Pharmacol 1989; 96: 186-192.
21. Nagata S., Kebo D. K., Kunkel S., Glovsky M. M. Effect of adenylate cyclase activators on C5a-induced human neutrophil aggregation, enzyme release and superoxide production. Int Arch Allergy Immunol 1992; 97: 194-199.
22. 2-integrin- and L-selectin-dependent in blood and isolated cells. J Immunol 1992; 149: 2765-2771.
23. Yuli I., Synderman R. Rapid changes in light scattering from human polymorphonuclear leukocytes exposed to chemoattraclants. J Clin Invest 1984; 73: 1408-1417
24. Lawrence R. A., Jones R. L. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br J Pharmacol 1992; 105: 817-824.
25. Coleman R. A., Grix S. P., Head S. A., Louttit J. B., Mallett A., Sheldrick R. L. G. A novel inhibitory receptor in piglet saphenous vein. Prostaglandins 1994; 47: 151-168.
26. Savage M. A., Moummi C., Karabatsos P. J., Lanthorn T. H. SC-46275: a potent and highly selective agonist at the EPS receptor. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 939-943.
27. 2. In: Hellewell P. G., Williams X J., eds. Immunopharmacology of Neutrophils. New York: Academic Press, 1994: 159-193.
28. Xie Z. H., Wise H. Neutrophil aggregation responses and the role of calcium. Asia-Pacific J Allergy Immunol 1995; 12: 178.
29. Svetlov S., Nigam S., Calphostin C., a specific protein kinase C inhibitor, activates human neutrophils: effect on phospholipase A2 and aggregation. Biochim Biophys Acta 1993; 1177: 75-78.
30. Wright C. D., Hoffman M. D. The protein kinase C inhibitors H-7 and H-9 fail to inhibit human neutrophil activation. Biochem Biophys Res Commun 1986; 135: 749-755.
31. Mori T., Ando M., Takagi K. Staurosporine and its derivatives enhance f-Met-Leu-Phe-induced superoxide production via phospholipase D activation in human polymorphonuclear leukocytes. Int J Clin Pharmacol Ther 1994; 32: 422-428.
32. Mitsuhashi M., Mitsuhashi T., Payan D. G. Multiple signaling pathways of histamine H2 receptors. J Biol Chem 1989; 264: 18356-18362.
33. Hadjokas N., Bayer C., Nielson C. P. Impaired stimulus-response coupling in association with increased growth rate of HL60 cells. J Leukot Biol 1992; 52: 157-160.